Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...
In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...
Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...
As the U.S. Treasury phases out the use of the penny, it’s creating a host of new challenges for businesses and consumers that could cost all of us a good chunk of change. That’s because eliminating ...
Measles outbreaks are spreading across the U.S., and the nation is likely to lose its status as a country where the disease is eliminated, something that infectious disease specialists say is directly ...
With just five weeks remaining in the regular season, all eyes in and around the NFL are on the playoff picture, and with good reason. The picture is as close and as muddied as it has ever been in ...
Plume, a real world asset (RWA)-focused blockchain project, has debuted its Nest yield vaults directly on Solana, giving the network’s users native access to institutional-grade real-world assets for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback